Tempero Pauses Alcohol Disorder Work, Mulls Options: Nxera
03 Nov 2025 //
FIERCE BIOTECH
Tempero Bio Secures $70 Million Series B Financing
24 Mar 2025 //
PR NEWSWIRE
Tempero Bio Announces FDA Clearance of IND Application for TMP-301
04 Jan 2023 //
PR NEWSWIRE

Market Place
Sourcing Support